The Phone Call That Changed Everything
Sarah Chen was reviewing quarterly projections when her phone rang on that October afternoon in 2018. Her small logistics software company was bleeding money, her investors were getting nervous, and she was working 80-hour weeks trying to keep everything afloat.
Photo: Sarah Chen, via img.discogs.com
The voice on the other end belonged to Dr. Martinez, her oncologist. The biopsy results were back. Pancreatic cancer, stage four. Six months, maybe nine if she was lucky.
Photo: Dr. Martinez, via reenergizedliving.com
Most entrepreneurs would have started planning their exit strategy. Chen hung up the phone and immediately called an emergency board meeting to propose the most aggressive expansion plan in her company's history.
"I remember thinking Sarah had lost her mind," recalled investor Mark Thompson. "Here she was, facing a terminal diagnosis, and she wanted to double our workforce and enter three new markets simultaneously. Everything about it violated basic business principles."
Chen's response was simple: "What's the worst that could happen? I die?"
When Tomorrow Becomes Optional
For three years, Chen had been running her company, LogiFlow, with the careful conservatism that business schools teach and investors expect. Steady growth, manageable risk, sustainable practices. The kind of approach that builds solid, unremarkable companies over decades.
But decades were no longer on the table.
"The diagnosis didn't give me a death sentence," Chen explained in a 2021 interview, three years past her supposed expiration date. "It gave me permission to stop being afraid of failure. When you're going to die anyway, 'playing it safe' becomes the riskiest strategy of all."
The first decision she made was counterintuitive: instead of scaling back to preserve cash, she decided to solve her customers' biggest problems, regardless of short-term profitability. LogiFlow had been offering incremental improvements to supply chain management. Chen pivoted to building the comprehensive platform her clients actually needed, even though it meant burning through their remaining capital at an alarming rate.
The Clarity That Comes With Countdown
"Before the diagnosis, I spent probably 40% of my time on activities that didn't directly serve our customers or advance our mission," Chen recalled. "Networking events where nothing happened, meetings about meetings, strategic planning sessions that were really just elaborate procrastination."
Facing mortality stripped away what she now calls "the luxury of inefficiency." Every decision got filtered through a simple question: If I only had six months to make this company matter, what would I do?
The answer was radical simplification. Chen eliminated every initiative that wasn't directly connected to solving customer problems. She fired vendors who were competent but not exceptional. She restructured her team around the three core functions that actually drove value, and let everything else go.
"Sarah became laser-focused in a way that was almost frightening," remembered Jennifer Walsh, LogiFlow's head of product development. "She'd walk into meetings and cut through weeks of debate with questions that got to the heart of what we were actually trying to accomplish. It was like she'd developed this supernatural ability to see through complexity to the essential truth underneath."
The Paradox of Reckless Prudence
What looked like reckless decision-making to outside observers was actually a more sophisticated form of risk management. Chen wasn't ignoring consequences — she was recalibrating which consequences mattered.
"Most business decisions are driven by fear of failure," explained Dr. Rebecca Santos, who studies decision-making under extreme conditions at Stanford Business School. "When that fear gets removed — either through confidence or, in Sarah's case, through confronting something much scarier than business failure — people often make much clearer strategic choices."
Photo: Stanford Business School, via c8.alamy.com
Chen's "reckless" expansion involved hiring senior developers and customer success specialists that the company couldn't technically afford. But instead of traditional employment contracts, she offered equity-heavy packages that aligned everyone's incentives with long-term success rather than short-term cash flow.
"I told every new hire exactly what was happening," Chen said. "I explained my diagnosis, our financial situation, and why I believed we could build something extraordinary in whatever time we had. People could choose to bet on us or not, but they couldn't say they didn't know what they were getting into."
When Urgency Meets Strategy
The combination of terminal urgency and strategic clarity produced results that surprised even Chen's most optimistic projections. LogiFlow's customer satisfaction scores jumped 40% within six months as the company focused exclusively on solving real problems rather than managing incremental improvements.
More importantly, the platform Chen's team built during this period addressed supply chain challenges that their competitors had been ignoring because they seemed too complex or too risky to tackle. While other companies played it safe with minor feature updates, LogiFlow was rebuilding logistics management from the ground up.
"Sarah's diagnosis forced us to think like a startup again," explained David Kim, LogiFlow's chief technology officer. "We stopped worrying about protecting our existing market position and started focusing on creating the market position we actually wanted. It was liberating in the strangest way."
By mid-2019, six months past Chen's original prognosis, LogiFlow had secured contracts with three Fortune 500 companies and was processing supply chain data for operations across 15 countries. Revenue had tripled, and the company was finally profitable.
The Treatment That Worked on Everything
Chen's cancer treatment was successful — a combination of experimental therapy and what her doctors diplomatically called "exceptional patient resilience." But by the time her oncologist declared her in remission in late 2020, LogiFlow had become something neither Chen nor her investors had originally envisioned.
"The company we built during those 18 months when I thought I was dying is completely different from the company we were building before," Chen reflected. "It's not just bigger or more profitable — it's more purposeful. We stopped trying to be everything to everyone and started being exactly what our best customers actually needed."
Today, LogiFlow employs over 400 people and has been acquired by a major technology conglomerate for $340 million. Chen remains as CEO, and her approach to decision-making — what she calls "mortality-informed strategy" — has become a case study in business schools.
The Lesson in Living Backwards
"Most people make business decisions as if they have infinite time to recover from mistakes," Chen observed. "But when you start from the assumption that time is limited, you stop optimizing for safety and start optimizing for impact."
Chen's story isn't just about beating cancer or building a successful company — it's about what becomes possible when we stop letting the fear of failure prevent us from attempting something meaningful. Her diagnosis didn't give her superpowers; it removed the psychological barriers that had been constraining her decision-making all along.
"I'm not recommending that everyone get a terminal diagnosis," she said with characteristic directness. "But I am suggesting that we all ask ourselves: If I knew my time was limited, what would I stop doing? What would I start doing? And why am I waiting for a countdown to give myself permission to live and work that way?"
Three years past her supposed expiration date, Chen is cancer-free, LogiFlow is thriving, and she's working on her next venture — a consulting firm that helps other entrepreneurs make decisions with the clarity that comes from understanding what really matters.
Sometimes it takes facing death to learn how to truly build something that lives.
